When the chief executive of a quantum computing company dumps nearly 688,000 shares in a single day, the optics are rarely good. Alan Baratz, CEO of D-Wave Quantum, pocketed roughly $18 million on June 8, 2026, through the sale of stock acquired at deeply discounted option prices. CFO John Markovich followed suit days later, unloading shares worth $1.34 million. Yet the usual alarm bells have remained conspicuously silent on Wall Street.
The reason is nuance. Baratz still holds more than three million shares after the transaction, and the sales were framed as part of routine financial and tax planning, according to mandatory SEC filings. Investors who panicked would have missed the bigger picture: D-Wave had just announced a multi-year contract with a Fortune-100 company, pushing quantum applications from the laboratory into live production environments. The company is shifting from one-off pilot projects toward a subscription-based model for quantum access — a fundamental change in how it generates recurring revenue.
That strategic pivot comes amid a jarring quarter. First‑quarter revenue collapsed by 81% year over year to $2.86 million, a drop driven entirely by a base effect: the prior year had included a multi‑million‑dollar system sale. Strip that out, and the underlying business tells a different story. D‑Wave finished the period with a cash pile of $588 million — a war chest that, together with a planned $100 million injection from the US government under the CHIPS and Science Act, buys the company years of runway while it chases commercial adoption.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Analysts are focusing on the technology, not the insider exit. Rosenblatt Securities reiterated its buy rating with a $43 price target, pointing to the promise of D‑Wave’s fault‑tolerant roadmap. That timeline calls for systems with up to 181 physical qubits by 2028, the first 10 logical qubits by 2030, and 100 logical qubits tailored for AI workloads by 2032. The average price target among covering analysts currently sits at €31.59 (about $34 at recent rates), representing more than 50% upside from the stock’s €20.55 close.
The chart, however, tells a less optimistic story. At €20.56, D‑Wave shares are trading just below the 200‑day moving average of €20.85 and more than 46% below the 52‑week peak of €38.48 hit last October. The relative strength index sits at a neutral 48.2, and the 30‑day volatility range remains a breathtaking 139%. If the stock slips under the 50‑day average of €18.57, technicians warn that a retest of the year’s lows could follow.
What the market demands now is proof that the new commercial narrative is real — not just a roadshow pitch. D‑Wave heads to London on June 18 for an investor conference with a market capitalisation of €7.55 billion. The backlog is growing, but so is the pressure to convert bookings into cash. For a company that has already survived the technology chasm, the next challenge is winning over the skeptics who watch the C‑suite selling shares even as the science advances.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from June 12 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 12.
D-Wave Quantum: Buy or sell? Read more here...
